Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injection could drastically cut bleeding episodes for hemophilia patients

NCT ID NCT05662319

Ongoing Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study is testing if a new drug called fitusiran, given as an injection, can better prevent bleeding episodes in males aged 12 and older who have severe hemophilia A or B. Participants will first be monitored on their current standard treatment, then switch to fitusiran for about three years to compare how often bleeds occur. The main goal is to see if fitusiran leads to fewer bleeds requiring treatment than the usual care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Center for Inherited Blood Disorders (CIBD) Site Number : 8400012

    Orange, California, 92868-4306, United States

  • Children's Medical Center Dallas- Site Number : 8400018

    Dallas, Texas, 75235, United States

  • Gulf States Hemophilia and Thrombophilia Center- Site Number : 8400002

    Houston, Texas, 77030, United States

  • Hackensack University Site Number : 8400009

    Hackensack, New Jersey, 07601, United States

  • Investigational Site Number : 1240001

    Hamilton, Ontario, L8N 3Z5, Canada

  • Investigational Site Number : 1240002

    Hamilton, Ontario, L8N 3Z5, Canada

  • Investigational Site Number : 1240004

    Toronto, Ontario, M5G 1X8, Canada

  • Investigational Site Number : 1560001

    Guangzhou, 510515, China

  • Investigational Site Number : 1560002

    Jinan, 250013, China

  • Investigational Site Number : 1560003

    Beijing, 100045, China

  • Investigational Site Number : 1580001

    Taipei, 100, Taiwan

  • Investigational Site Number : 1580003

    Taipei, 11031, Taiwan

  • Investigational Site Number : 2500001

    Paris, 75015, France

  • Investigational Site Number : 2500002

    Lille, 59037, France

  • Investigational Site Number : 2500003

    Le Kremlin-Bicêtre, 94275, France

  • Investigational Site Number : 2760001

    Berlin, 10249, Germany

  • Investigational Site Number : 2760002

    Hamburg, 20246, Germany

  • Investigational Site Number : 3000001

    Athens, 115 27, Greece

  • Investigational Site Number : 3000002

    Athens, 11527, Greece

  • Investigational Site Number : 3560001

    Pune-411011, 411 011, India

  • Investigational Site Number : 3560003

    Vellore, 632004, India

  • Investigational Site Number : 3560004

    Bangalore, 560 034, India

  • Investigational Site Number : 3560006

    Punjab, 141008, India

  • Investigational Site Number : 3560007

    Bhubaneswar, 751019, India

  • Investigational Site Number : 3800001

    Milan, 20122, Italy

  • Investigational Site Number : 3800003

    Rozzano, Milano, 20089, Italy

  • Investigational Site Number : 3920001

    Kashihara-shi, Nara, 634-8522, Japan

  • Investigational Site Number : 3920002

    Saitama-shi, Saitama, 330-8777, Japan

  • Investigational Site Number : 3920003

    Nagoya, Aichi-ken, 4668560, Japan

  • Investigational Site Number : 4100001

    Seoul, Seoul-teukbyeolsi, 03722, South Korea

  • Investigational Site Number : 4100002

    Seoul, Seoul-teukbyeolsi, 05278, South Korea

  • Investigational Site Number : 4840001

    Veracruz, 91900, Mexico

  • Investigational Site Number : 4840002

    Monterrey, Nuevo León, 64460, Mexico

  • Investigational Site Number : 4840004

    Chihuahua City, 31000, Mexico

  • Investigational Site Number : 6160001

    Warsaw, Masovian Voivodeship, 02-776, Poland

  • Investigational Site Number : 6160002

    Krakow, Lesser Poland Voivodeship, 30-688, Poland

  • Investigational Site Number : 6160004

    Lodz, Lódzkie, 93-510, Poland

  • Investigational Site Number : 6820002

    Jeddah, 21423, Saudi Arabia

  • Investigational Site Number : 7100001

    Parktown, 2193, South Africa

  • Investigational Site Number : 7100003

    Johannesburg, 1501, South Africa

  • Investigational Site Number : 7240002

    A Coruña, A Coruña [La Coruña], 15006, Spain

  • Investigational Site Number : 7240003

    Zaragoza, 50009, Spain

  • Investigational Site Number : 7920001

    Çapa, 34390, Turkey (Türkiye)

  • Investigational Site Number : 7920002

    Adana, 01130, Turkey (Türkiye)

  • Investigational Site Number : 7920003

    Izmir, TR-35100, Turkey (Türkiye)

  • Investigational Site Number : 7920004

    Akdeniz, 07059, Turkey (Türkiye)

  • M Health Fairview University of Minnesota Medical Center - West Bank- Site Number : 8400016

    Minneapolis, Minnesota, 55454, United States

  • Northwell Health Hemostasis and Thrombosis Center Site Number : 8400015

    New Hyde Park, New York, 11040, United States

  • UPMC Children's Hospital of Pittsburgh-4401 Penn Ave Site Number : 8400017

    Pittsburgh, Pennsylvania, 15224-1334, United States

  • University Hospitals of Cleveland Site Number : 8400001

    Cleveland, Ohio, 44106, United States

Conditions

Explore the condition pages connected to this study.

HEMOPHILIA